Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
AssigneeNutramax Laboratories, Inc.
InventorsRobert W. Henderson, Tarek Hammad
Life of this patent
Estimating the term…
Loading patent…
AssigneeNutramax Laboratories, Inc.
InventorsRobert W. Henderson, Tarek Hammad
Estimating the term…
A composition for the protection, treatment and repair and for reducing the inflammation of connective tissue in mammals and a method for the treatment of connective tissue in mammals by the administration of the composition. The composition includes S-Adenosylmethionine (SAM), and a component selected from an aminosugar or salts thereof (e.g., glucosamine) or glycosaminoglycans (e.g., chondroitin salts) or mixtures or fragments thereof. The composition optionally includes manganese which promotes the production of connective tissue matrix. The composition also optionally includes methyl donors or methyl donor cofactors, such as vitamin B12, vitamin B6, folic acid, dimethylglycine or trimethylglycine.
A composition for treatment and repair and for reducing the inflammation of connective tissue in humans and animals comprising S-Adenosylmethionine in combination with fragments of a glycosaminoglycan selected from the group consisting of chondroitin, chondroitin salts and mixtures thereof.
A composition for treatment and repair and for reducing the inflammation of connective tissue in humans and animals comprising:
Dependencies are inferred from the claim text.